GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO Aug. 22, 2018
Angiotensin II activates a macrophage-to-sensory neuron crosstalk in peripheral pain sensitization Aug. 22, 2018
Uncovering the regulatory role of a prognostic microRNA in pancreatic ductal adenocarcinoma Aug. 22, 2018
FDA approves expanded label for Keytruda for first-line treatment of metastatic non-squamous NSCLC Aug. 21, 2018
Phase II trial of TLC-599 for osteoarthritis pain meets primary and key secondary endpoints Aug. 21, 2018
RSS